These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36574946)

  • 1. Enhancement of the antitumor effect of 5-fluorouracil with modulation in drug transporters expression using PI3K inhibitors in colorectal cancer cells.
    El-Daly SM; Abo-Elfadl MT; Hussein J; Abo-Zeid MAM
    Life Sci; 2023 Feb; 315():121320. PubMed ID: 36574946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM97 knockdown inhibits 5-fluorouracil resistance by regulating epithelial-mesenchymal transition and ABC transporter expression via inactivating the Akt/mTOR pathway in 5-fluorouracil-resistant colorectal cancer cells.
    Xu Y; Tang Y; Xu Q; He W
    Chem Biol Drug Des; 2024 Feb; 103(2):e14490. PubMed ID: 38388887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
    Yu S; Wu C; Tan Q; Liu H
    J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wortmannin Inhibits Cell Growth and Induces Apoptosis in Colorectal Cancer Cells by Suppressing the PI3K/AKT Pathway.
    Bani N; Rahmani F; Shakour N; Amerizadeh F; Khalili-Tanha G; Khazaei M; Hassanian SM; Kerachian MA; Abbaszadegan MR; Mojarad M; Hadizadeh F; Ferns GA; Avan A
    Anticancer Agents Med Chem; 2024; 24(12):916-927. PubMed ID: 38584531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
    Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hydroxysafflor yellow A inhibits proliferation, migration, and chemoresistance of colorectal cancer cells through Akt/mTOR-autophagy pathway].
    Wang L; Li F; Gu NN; Shen H; Han CL; Li KY; Yan RY; Wang J; Mi ZK
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):517-524. PubMed ID: 36725241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 9. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
    Sun LT; Zhang LY; Shan FY; Shen MH; Ruan SM
    Chin J Nat Med; 2021 Feb; 19(2):143-152. PubMed ID: 33641785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells.
    Bhattacharya B; Akram M; Balasubramanian I; Tam KK; Koh KX; Yee MQ; Soong R
    Cancer Biol Ther; 2012 Jan; 13(1):34-42. PubMed ID: 22336586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extract of
    Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
    World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
    Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
    Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis.
    Chen H; Deng J; Hou TW; Shan YQ
    J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
    Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
    Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo anti-colorectal cancer effect of the newly synthesized sericin/propolis/fluorouracil nanoplatform through modulation of PI3K/AKT/mTOR pathway.
    Diab SE; Tayea NA; Elwakil BH; Elshewemi SS; Gad AAEM; Abdulmalek SA; Ghareeb DA; Olama ZA
    Sci Rep; 2024 Jan; 14(1):2433. PubMed ID: 38286826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway.
    Huang SZ; Liu WY; Huang Y; Shen AL; Liu LY; Peng J
    Chin J Integr Med; 2019 Feb; 25(2):116-121. PubMed ID: 29948597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
    Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumae longae Rhizoma (Jianghuang) extract reverses the 5-Fluoruracil resistance in colorectal cancer cells via TLR4/PI3K/Akt/mTOR pathway.
    Teng Z; Sun X; Guo Y; Zhang M; Liu Y; Xu M
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101976. PubMed ID: 35710041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.
    Shin JY; Kim JO; Lee SK; Chae HS; Kang JH
    BMC Cancer; 2010 Aug; 10():425. PubMed ID: 20704765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.